Simona Giovannelli

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

Valentina Guarneri, Simona Giovannelli, Guido Ficarra et al. · The Oncologist · 2008 · 152 citations · Full text

Renal Safety and Efficacy of i.v. Bisphosphonates in Patients with Skeletal Metastases Treated for up to 10 Years

Valentina Guarneri, Sara Donati, Massimiliano Nicolini et al. · The Oncologist · 2005 · 87 citations · Full text

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy

Valentina Guarneri, Federico Piacentini, Guido Ficarra et al. · Annals of Oncology · 2009 · 78 citations · Full text

Residual Disease, Nodal Status, Surgical Oncology +10

Preoperative Chemotherapy plus Lapatinib or Trastuzumab or Both in HER2-Positive Operable Breast Cancer (CHERLOB Trial)

Valentina Guarneri, Antonio Frassoldati, Federico Piacentini et al. · Clinical Breast Cancer · 2008 · 30 citations · Full text

Preoperative Chemotherapy, Surgical Oncology, Breast Oncology +9

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

Valentina Guarneri, Antonio Frassoldati, Guido Ficarra et al. · Breast Cancer Research and Treatment · 2007 · 21 citations · Full text

Surgical Oncology, Oncology, Breast Oncology +8